Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK

Metformin (1,1-dimethylbiguanide hydrochloride) is the most commonly used drug to treat type II diabetic patients. It is believed that this drug has several other beneficial effects, such as anti-inflammatory and anticancer effects. Here, we wanted to evaluate the effect of metformin on the producti...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Rana M. Nassif, Elias Chalhoub, Pia Chedid, Margarita Hurtado-Nedelec, Elia Raya, Pham My-Chan Dang, Jean-Claude Marie, Jamel El-Benna
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Subjects:	metformin macrophage inflammation ROS NADPH oxidase NOX2
Online Access:	https://www.mdpi.com/2227-9059/10/2/319